Risk-adapted treatment for childhood hepatoblastoma
Top Cited Papers
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (3), 411-421
- https://doi.org/10.1016/j.ejca.2003.06.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of Unresectable and Metastatic Hepatoblastoma: A Pediatric Oncology Group Phase II StudyJournal of Clinical Oncology, 2002
- Pretreatment prognostic factors and treatment results in children with hepatoblastomaCancer, 2002
- Hepatoblastoma presenting with lung metastasesCancer, 2000
- Prognostic factors and staging systems in childhood hepatoblastomaInternational Journal of Cancer, 1997
- Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastomaEuropean Journal Of Cancer, 1997
- Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastomaJournal of Pediatric Surgery, 1991
- Cisplatin ototoxicity in children: A practical grading systemMedical and Pediatric Oncology, 1991
- Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastomaMedical and Pediatric Oncology, 1985
- Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of pediatrics surgical section survey — 1974Journal of Pediatric Surgery, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958